Daiwa Securities Group
CNST

Daiwa Securities Group’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Daiwa Securities Group’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-89
Closed -$3K – 1369
2021
Q2 		$3K Hold
89
– – ﹤0.01% 1127
2021
Q1 		$2K Hold
89
– – ﹤0.01% 1175
2020
Q4 		$3K Buy
+89
New +$2.24K ﹤0.01% 1105

Daiwa Securities Group's CNST Position: Q3 2021 in Review

Daiwa Securities Group sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 89 shares — an estimated $3K sold.

Daiwa Securities Group first reported a position in CNST in Q4 2020 and held it in 3 quarters. The position peaked at $3K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Daiwa Securities Group reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Daiwa Securities Group sold 89 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $3K.
  • Daiwa Securities Group first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2020 and held it in 3 quarters.
  • Daiwa Securities Group's Constellation Pharmaceuticals, Inc. position peaked at $3K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Daiwa Securities Group's 13F filing for Q3 2021, filed 5 Nov 2021.